Occam Places CEO Shakti Narayan, JD, PhD for Oncology Biotech Accent Therapeutics
In September 2019, Occam recruited Shakti Narayan, JD, PhD, as Chief Executive Officer of Accent Therapeutics. Narayan is a highly accomplished and very evolved biotech strategy and business development leader with a long suit in oncology.
Narayan most recently served as the Chief Business Officer at Tango Therapeutics, where he was responsible for finance, business development, and operational functions. While at Tango, he led a partnership with Gilead Sciences valued at $1.7 billion, which proved transformational. Prior to his work at Tango, Narayan was the VP and Head of Transactions at Johnson & Johnson Innovation, where he helped establish J&J's Innovation Centers model and led oncology business development. Narayan began his biotech career in business development at Genentech.
Occam Global is a biotech executive search, recruiting, and leadership advisory firm with specialties across technological fields, including Biotech, TechBio, AI-ML, Cell/Gene Therapy, Diagnostics/Genomics, Medical Devices, Research Tools, Digital Health, Alternative Energy, AgTech, EdTech, Robotics as well as adjacencies within Venture Capital and Private Equity. Occam helps build biotech executive leadership teams that meet the demands of the rapidly developing, competitive, and challenging industries it serves. Occam Global recruits leading C-Suite executives and board members for the most exciting and innovative clients across the world with a specific focus on the UK, Continental Europe, the US, and Asia.